REED'S INC (REED)

US7583383051 - Common Stock

3.24  -0.19 (-5.54%)

After market: 3.37 +0.13 (+4.01%)

Fundamental Rating

2

Overall REED gets a fundamental rating of 2 out of 10. We evaluated REED against 33 industry peers in the Beverages industry. REED has a bad profitability rating. Also its financial health evaluation is rather negative. REED is quite expensive at the moment. It does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

In the past year REED has reported negative net income.
REED had a negative operating cash flow in the past year.

1.2 Ratios

REED has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

REED has a Gross Margin of 22.19%. This is amonst the worse of the industry: REED underperforms 85.29% of its industry peers.
REED's Gross Margin has improved in the last couple of years.
REED does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 22.19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.74%
GM growth 5Y4.73%

1

2. Health

2.1 Basic Checks

REED does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for REED has been reduced compared to 1 year ago.
REED has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -5.11, we must say that REED is in the distress zone and has some risk of bankruptcy.
REED has a Altman-Z score of -5.11. This is in the lower half of the industry: REED underperforms 73.53% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -5.11
ROIC/WACCN/A
WACC11.25%

2.3 Liquidity

A Current Ratio of 1.14 indicates that REED should not have too much problems paying its short term obligations.
REED has a worse Current ratio (1.14) than 73.53% of its industry peers.
REED has a Quick Ratio of 1.14. This is a bad value and indicates that REED is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.35, REED is doing worse than 88.24% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 0.35

5

3. Growth

3.1 Past

The earnings per share for REED have decreased strongly by -3993.75% in the last year.
The Revenue has been growing slightly by 6.90% in the past year.
The Revenue has been growing slightly by 3.15% on average over the past years.
EPS 1Y (TTM)-3993.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3650%
Revenue 1Y (TTM)6.9%
Revenue growth 3Y9.19%
Revenue growth 5Y3.15%
Sales Q2Q%-9.76%

3.2 Future

The Earnings Per Share is expected to grow by 23.94% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 22.78% on average over the next years. This is a very strong growth
EPS Next Y10%
EPS Next 2Y23.29%
EPS Next 3Y20.74%
EPS Next 5Y23.94%
Revenue Next Year8.83%
Revenue Next 2Y10.89%
Revenue Next 3Y11.26%
Revenue Next 5Y22.78%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

REED reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year REED is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

REED's earnings are expected to grow with 20.74% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.29%
EPS Next 3Y20.74%

0

5. Dividend

5.1 Amount

REED does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

REED'S INC

NASDAQ:REED (2/15/2023, 8:19:32 PM)

After market: 3.37 +0.13 (+4.01%)

3.24

-0.19 (-5.54%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)11-10 2022-11-10/amc
Earnings (Next)03-29 2023-03-29/amc
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners426.61%
Ins Owner Change0%
Market Cap8.17M
Analysts80
Price Target0.77 (-76.23%)
Short Float %0.18%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-20.1%
Min EPS beat(2)-22.55%
Max EPS beat(2)-17.65%
EPS beat(4)0
Avg EPS beat(4)-14.52%
Min EPS beat(4)-22.55%
Max EPS beat(4)-8.93%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-18.11%
Min Revenue beat(2)-29.87%
Max Revenue beat(2)-6.35%
Revenue beat(4)0
Avg Revenue beat(4)-12.2%
Min Revenue beat(4)-29.87%
Max Revenue beat(4)-3.79%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-4900%
EPS NQ rev (3m)-4900%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.45%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.76%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-9.16%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.16
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-6.55
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)-7.55
FCFYN/A
OCF(TTM)-7.45
OCFYN/A
SpS20.15
BVpS-1.36
TBVpS-1.61
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 22.19%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.74%
GM growth 5Y4.73%
F-Score0
Asset Turnover1.68
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 550%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 0.35
Altman-Z -5.11
F-Score0
WACC11.25%
ROIC/WACCN/A
Cap/Depr(3y)298.21%
Cap/Depr(5y)243.94%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3993.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3650%
EPS Next Y10%
EPS Next 2Y23.29%
EPS Next 3Y20.74%
EPS Next 5Y23.94%
Revenue 1Y (TTM)6.9%
Revenue growth 3Y9.19%
Revenue growth 5Y3.15%
Sales Q2Q%-9.76%
Revenue Next Year8.83%
Revenue Next 2Y10.89%
Revenue Next 3Y11.26%
Revenue Next 5Y22.78%
EBIT growth 1Y-8.79%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year32.64%
EBIT Next 3Y34.59%
EBIT Next 5Y29.88%
FCF growth 1Y-81.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-82.44%
OCF growth 3YN/A
OCF growth 5YN/A